Bowman & Co S.C. Acquires 861 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Bowman & Co S.C. lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 28.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,936 shares of the healthcare conglomerate's stock after acquiring an additional 861 shares during the period. UnitedHealth Group makes up approximately 1.0% of Bowman & Co S.C.'s portfolio, making the stock its 26th biggest position. Bowman & Co S.C.'s holdings in UnitedHealth Group were worth $1,997,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Pacer Advisors Inc. raised its holdings in shares of UnitedHealth Group by 5.7% during the second quarter. Pacer Advisors Inc. now owns 65,860 shares of the healthcare conglomerate's stock valued at $33,540,000 after purchasing an additional 3,525 shares during the period. Garden State Investment Advisory Services LLC boosted its holdings in UnitedHealth Group by 13.5% in the second quarter. Garden State Investment Advisory Services LLC now owns 1,049 shares of the healthcare conglomerate's stock worth $536,000 after acquiring an additional 125 shares in the last quarter. Columbus Hill Capital Management L.P. acquired a new position in shares of UnitedHealth Group during the second quarter worth approximately $14,789,000. Summit Trail Advisors LLC increased its stake in UnitedHealth Group by 33.3% during the 2nd quarter. Summit Trail Advisors LLC now owns 12,008 shares of the healthcare conglomerate's stock valued at $6,115,000 after purchasing an additional 2,999 shares in the last quarter. Finally, Transatlantique Private Wealth LLC grew its holdings in shares of UnitedHealth Group by 9.9% during the second quarter. Transatlantique Private Wealth LLC now owns 2,594 shares of the healthcare conglomerate's stock valued at $1,291,000 after buying an additional 234 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 16th. Truist Financial cut their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. UBS Group lowered their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a research report on Wednesday, October 16th. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday. Finally, Stephens raised their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research report on Thursday, December 5th. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $627.74.

UnitedHealth Group Price Performance

Shares of UNH traded down $0.56 during mid-day trading on Friday, reaching $510.03. 7,462,712 shares of the stock traded hands, compared to its average volume of 5,104,531. The company has a market cap of $469.38 billion, a price-to-earnings ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a fifty day moving average price of $549.37 and a 200 day moving average price of $563.18. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company's revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter last year, the company posted $5.83 EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.